SAVR contemporary outcomes in TAVI era: Still a valid option for the future.
aortic valve replacement
aortic valve stenosis
cardiac surgery
outcomes
transcatheter valvular therapies
Journal
Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
05
02
2021
accepted:
06
02
2021
pubmed:
23
2
2021
medline:
15
5
2021
entrez:
22
2
2021
Statut:
ppublish
Résumé
The advent of transcatheter aortic valve implantation (TAVI) has changed the way aortic stenosis (AS) is treated. In the last decade, the improvement of techniques and the development of more performing devices helped in granting TAVI approval for its use in high- and intermediate-risk patients and more recently in low-risk patients. With the majority of surgical aortic valve replacement (SAVR) procedures being done on low-risk patients, recent results from the PARTNER 3 and Evolut Low Risk trials have ignited the question of TAVI use in patient category as well as an alternative to SAVR. The paper by a group from the Royal Papworth Hospital from the University of Cambridge, UK, published in the Journal of Cardiac Surgery, should serve as concrete proof that SAVR remains an excellent option with favorable outcomes in the treatment of AS. It is a wake-up call to the entire surgical community to push forward to ameliorate outcomes and reduce complications through innovation and experience, newer surgical techniques, better equipment, and improved valves to adapt to the changing world of heart valve diseases.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1477-1478Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Kolte D, Vlahakes GJ, Palacios IF, et al. Transcatheter versus surgical aortic valve replacement in low-risk patients. J Am Coll Cardiol. 2019;74(12):1532-1540.
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706-1715.
Sumal AS, Ali JM, Kyriacou H, Tuttle CJ, Moorjani N. Aortic valve replacement in patients over 60: Real-world surgical outcomes. J Card Surg. 2021.
Thourani VH, Suri RM, Gunter RL, et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. Ann Thorac Surg. 2015;99(1):55-61.
Rahimtoola SH. Choice of prosthetic heart valve in adults an update. J Am Coll Cardiol. 2010;55(22):2413-2426.
Thourani VH, Forcillo J, Szeto WY, et al. Outcomes in 937 intermediate-risk patients undergoing surgical aortic valve replacement in PARTNER-2A. Ann Thorac Surg. 2018;105(5):1322-1329.
Khalil KN, Boukhris M, Badreddine M, et al. Changes in outcomes over time in intermediate-risk patients treated for severe aortic stenosis. J Card Surg. 2020;35:3422-3429.